the patient was prescribed prednisone 10 mg orally daily and his warfarin dosage was decreased to 9 mg weekly. c During this visit, the patient’s warfarin dosage was decreased to 9.5 mg weekly.

The aims of this study are (a) to test if 12.5 mg prednisone daily is an adequate starting dose in PMR and (b) to evaluate the factors that could predict a positive response to this initial dose.

Taxane chemotherapy is unable to sensitize prostate cancer to immune checkpoint inhibitors, resulting in another negative trial with immunotherapy in prostate cancer,” said Andrea Necchi, MD.

Findings from MINT will be presented at the American Academy of Neurology Annual Meeting on April 8, 2025, in San Diego.

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...

Objectives: To study the efficacy of hydroxychloroquine (HCQ) 400 mg daily in patients with mucocutaneous ... The majority of patients used prednisone at baseline (58.5%) and at follow-up (57.4%). In ...

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Factors associated with recurrence in a multivariable analysis included younger age (60 years and older versus younger than 40 years: rate ratio, 0.11), prednisone treatment (≥20 versus 0 mg: rate ...